Laboratory-confirmed invasive meningococcal disease: Effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011

Eurosurveillance

Volumn 18, Issue 37, 2013, Pages

  Memish, Z ^a,b   Al Hakeem, R ^a   Al Neel, O ^a   Danis, K ^c,d   Jasir, A ^c   Eibach, D ^e  

^a MINISTRY OF HEALTH   (Saudi Arabia)

^b ALFAISAL UNIVERSITY   (Saudi Arabia)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^d INSTITUT DE VEILLE SANITAIRE   (France)

^e UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DISEASE SURVEILLANCE; EPIDEMIC; FEMALE; HEALTH PROGRAM; HUMAN; INCIDENCE; INFANT; LATEX AGGLUTINATION TEST; MALE; MENINGOCOCCOSIS; MORBIDITY; MORTALITY; NEISSERIA MENINGITIDIS; NEWBORN; SAUDI ARABIA; SEASONAL VARIATION; SEROLOGY; VACCINATION;

EID: 84884251239     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2013.18.37.20581     Document Type: Article

References (37)

1. Visintin C, Mugglestone MA, Fields EJ, Jacklin P, Murphy MS, Pollard AJ et al. Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance. BMJ. 2010;340:c3209. http://dx.doi.org/10.1136/bmj.c3209. PMid:20584794.
2. Pollard AJ, Nadel S, Ninis N, Faust SN, Levin M. Emergency management of meningococcal disease: eight years on. Arch Dis Child. 2007;92(4):283-6. http://dx.doi.org/10.1136/adc.2006.102384. PMid:17376933. PMCid:PMC2083684.
3. Chang Q, Tzeng YL, Stephens DS. Meningococcal disease: changes in epidemiology and prevention. Clin Epidemiol. 2012;4:237-45.PMid:23071402. PMCid:PMC3470458.
4. Wilder-Smith A. Meningococcal vaccine in travelers. Curr Opin Infect Dis. 2007;20(5):454-60. http://dx.doi.org/10.1097/QCO.0b013e3282a64700. PMid:17762777.
5. Vipond C, Care R, Feavers IM. History of meningococcal vaccines and their serological correlates of protection. Vaccine. 2012;30 Suppl 2:B10-7. http://dx.doi.org/10.1016/j.vaccine.2011.12.060. PMid:22607894.
6. World Health Organization. Global Advisory Committee on Vaccine Safety, 12-13 December 2007. Wkly Epidemiol. Rec. 2008;83(4):37-44. PMid:18219807.
7. Ahmed QA, Arabi YM, Memish ZA. Health risks at the Hajj. Lancet. 2006;367(9515):1008-15. http://dx.doi.org/10.1016/S0140-6736(06)68429-8
8. Aguilera JF, Perrocheau A, Meffre C, Hahné S; W135 Working Group. Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000. Emerg Infect Dis. 2002;8(8):761-7. http://dx.doi.org/10.3201/eid0808.010422. PMCid:PMC2732506.
9. Memish ZA. Meningococcal disease and travel. Clin Infect Dis. 2002;34(1): 84-90. http://dx.doi.org/10.1086/323403. PMid:11731951.
10. Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009; 27 Suppl 2:B51-63. http://dx.doi.org/10.1016/j.vaccine.2009.04.063. PMid:19477562.
11. al-Gahtani YM, el Bushra HE, al-Qarawi SM, al-Zubaidi AA, Fontaine RE. Epidemiological investigation of an outbreak of meningococcal meningitis in Makkah (Mecca), Saudi Arabia, 1992. Epidemiol Infect. 1995;115(3):399-409. http://dx.doi.org/10.1017/S0950268800058556. PMid:8557071. PMCid:PMC2271597.
12. Trotter CL, Greenwood BM. Meningococcal carriage in the African meningitis belt. Lancet Infect Dis. 2007;7(12):797-803.http://dx.doi.org/10.1016/S1473-3099(07)70288-8
13. Caugant DA, Høiby EA, Magnus P, Scheel O, Hoel T, Bjune G, et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol. 1994;32(2):323-30. PMid:8150942. PMCid:PMC263032.
14. Centers for Disease Control and Prevention (CDC). VPD Surveillance Manual, 5th Edition, Atlanta; CDC; 2011. Chapter 8, Meningococcal Disease. [Accessed 09 Aug 2013]. Available from: http://www.cdc.gov/vaccines/pubs/surv-manual/chpt08-mening.pdf
15. Memish ZA, Venkatesh S, Ahmed QA. Travel epidemiology: the Saudi perspective. Int J Antimicrob Agents. 2003;21(2): 96-101.http://dx.doi.org/10.1016/S0924-8579(02)00364-3
16. Wilder-Smith A, Memish Z. Meningococcal disease and travel. Int J Antimicrob Agents. 2003;21(2):102-6. http://dx.doi.org/10.1016/S0924-8579(02)00284-4
17. Al-Mazrou YY, Al-Jeffri MH, Abdalla MN, Elgizouli SA, Mishskas AA. Changes in epidemiological pattern of Meningococcal disease in Saudi Arabia. Does it constitute a new challenge for prevention and control? Saudi Med J. 2004;25(10):1410-3. PMid:15494812.
18. World Health Organization. Health conditions for travellers to Saudi Arabia pilgrimage to Mecca (Hajj). Wkly Epidemiol Rec. 2005;80(49-50):431-2. PMid:16372666.
19. Olcén P, Fredlund H. Isolation and characterization of Neisseria meningitidis in the vaccine era. Who needs what and when? Scand J Infect Dis. 2010;42(1):4-11. http://dx.doi.org/10.3109/00365540903311177. PMid:19883161.
20. World Health Organization (WHO). Control of epidemic meningococcal disease. WHO practical guidelines. 2nd edition. Geneva: WHO; 1998.
21. United Nations Development Programme (UNDP). International Human Development Indicators. New York: UNPD. [Accessed 29 Jan 2013]. Available from: http://hdr.undp.org/en/statistics/
22. Ministry of Hajj, Kingdom of Saudi Arabia. [Accessed 10 Sep 2013]. Available from: http://www.hajinformation.com
23. Harrison LH, Pass MA, Mendelsohn AB, Egri M, Rosenstein NE, Bustamante A, et al. Invasive meningococcal disease in adolescents and young adults. JAMA. 2001;286(6):694-9. http://dx.doi.org/10.1001/jama.286.6.694. PMid:11495619.
24. Shigematsu M, Davison KL, Charlett A, Crowcroft NS. National enhanced surveillance of meningococcal disease in England, Wales and Northern Ireland, January 1999-June 2001. Epidemiol Infect. 2002;129(3):459-70. http://dx.doi.org/10.1017/S0950268802007549. PMid:12558328. PMCid:PMC2869907.
25. Robert Koch Institut (RKI). Invasive Meningokokken-Erkrankungen im Jahr 2007. Epidemiologisches Bulletin. 2008;32:265-72. German.
26. Ladhani SN, Flood JS, Ramsay ME, Campbell H, Gray SJ, Kaczmarski EB, et al. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. Vaccine. 2012;30(24):3710-6. http://dx.doi.org/10.1016/j.vaccine.2012.03.011. PMid:22429756.
27. Olivares R, Bouyer J, Hubert B. Risk factors for death in meningococcal disease. Pathol Biol (Paris). 1993;41(2):164-8.
28. Steindl G, Liu YL, Schmid D, Orendi U, Kormann-Klement A, Heuberger S. Epidemiology of invasive meningococcal disease in Austria 2010. Wien Klin Wochenschr. 2011;123 Suppl 1:10-4. http://dx.doi.org/10.1007/s00508-011-0058-0. PMid:21935643.
29. Connolly M, Noah N. Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6. European Meningitis Surveillance Group. Epidemiol Infect. 1999;122(1):41-9. http://dx.doi.org/10.1017/S0950268898001848. PMid:10098784. PMCid:PMC2809586.
30. European Centre for Disease Prevention and Control (ECDC). Case definitions. 2008 EU Case Definition (2008/426/EC) for meningococcal disease, invasive. Stockholm: ECDC. [Accessed 29 Jun 2013]. Available from: http://www.ecdc.europa.eu/en/activities/surveillance/EU_IBD/Pages/Case_definition.aspx
31. Australian Government, Department of Health and Ageing. Australian national notifiable diseases case definitions. Meningococcal disease (invasive) surveillance case definition - V1.4. Canberra: Australian Government, Department of Health and Ageing. [Accessed 29 Jun 2013]. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_mening.htm
32. Ni H, Knight AI, Cartwright K, Palmer WH, McFadden J. Polymerase chain reaction for diagnosis of meningococcal meningitis. Lancet. 1992;340(8833):1432-4. http://dx.doi.org/10.1016/0140-6736(92)92622-M
33. Corless CE, Guiver M, Borrow R, Edwards-Jones V, Fox AJ, Kaczmarski EB. Simultaneous Detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in Suspected Cases of Meningitis and Septicemia Using Real-Time PCR. J Clin Microbiol. 2001;39(4):1553-8. http://dx.doi.org/10.1128/JCM.39.4.1553-1558.2001. PMid:11283086. PMCid:PMC87969.
34. Wilder-Smith A, Goh KT, Barkham T, Paton NI. Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers. Clin Infect Dis. 2003;36(6):679-83.http://dx.doi.org/10.1086/367858. PMid:12627350.
35. Swartley JS, Marfin AA, Edupuganti S, Liu LJ, Cieslak P, Perkins B, et al. Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci USA. 1997;94(1):271-6. http://dx.doi.org/10.1073/pnas.94.1.271. PMid:8990198. PMCid:PMC19312.
36. Vogel U, Claus H, Frosch M. Rapid serogroup switching in Neisseria meningitidis. N Engl J Med. 2000;342(3):219-20.http://dx.doi.org/10.1056/NEJM200001203420319. PMid:10651563.
37. El Bashir H, Rashid H, Memish ZA, Shafi S; Health at Hajj and Umra Research group. Meningococcal vaccine coverage in Hajj pilgrims. Lancet. 2007;369(9570):1343. http://dx.doi.org/10.1016/S0140-6736(07)60625-4